Interpace Biosciences, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Servicestothe Health Industry
DGXQuest Diagnostics, Inc. -0.57%124.474.2%$161.36m
LHLaboratory Corp. of America Holdings 0.31%229.152.4%$145.85m
IQVIQVIA Holdings, Inc. -1.01%185.790.0%$134.82m
SYNHSyneos Health, Inc. 0.88%76.090.0%$45.75m
AMEHApollo Medical Holdings, Inc. 0.72%22.360.0%$2.49m
BASIBioanalytical Systems, Inc. -2.01%14.660.2%$1.89m
NRCNational Research Corp. 1.71%48.310.0%$1.62m
PLXProtalix Biotherapeutics, Inc. -0.11%4.6025.3%$1.13m
IDXGInterpace Biosciences, Inc. -3.82%4.0322.7%$0.56m
PMDPsychemedics Corp. 2.24%5.480.7%$0.40m

Company Profile

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.